Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.
- DOI
- 10.1097/md.0000000000025223
- Published
- 2021 Apr 2
- Container
- Medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/md.0000000000025223,
title = {Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.},
author = {Alegre-Sancho JJ and Juanola X and Rodríguez-Heredia JM and Manero J and Villa-Blanco I and Laiz A and Arteaga MJ and Cea-Calvo L and González CM},
year = {2021},
journal = {Medicine},
doi = {10.1097/md.0000000000025223},
url = {https://doi.org/10.1097/md.0000000000025223}
}RIS
TY - JOUR TI - Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study. AU - Alegre-Sancho JJ AU - Juanola X AU - Rodríguez-Heredia JM AU - Manero J AU - Villa-Blanco I AU - Laiz A AU - Arteaga MJ AU - Cea-Calvo L AU - González CM PY - 2021 JO - Medicine DO - 10.1097/md.0000000000025223 UR - https://doi.org/10.1097/md.0000000000025223 ER -
APA
JJ, A., X, J., JM, R., J, M., I, V., A, L., MJ, A., L, C., & CM, G. (2021). Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.. Medicine. https://doi.org/10.1097/md.0000000000025223
Source records
- pubmed · retrieved 2026-09-26T11:30:13.644Z